• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 的转互补系统再现了真实的病毒复制而没有毒力。

A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence.

机构信息

Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.

Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA; Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, TX, USA.

出版信息

Cell. 2021 Apr 15;184(8):2229-2238.e13. doi: 10.1016/j.cell.2021.02.044. Epub 2021 Feb 23.

DOI:
10.1016/j.cell.2021.02.044
PMID:33691138
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7901297/
Abstract

The biosafety level 3 (BSL-3) requirement to culture severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a bottleneck for research. Here, we report a trans-complementation system that produces single-round infectious SARS-CoV-2 that recapitulates authentic viral replication. We demonstrate that the single-round infectious SARS-CoV-2 can be used at BSL-2 laboratories for high-throughput neutralization and antiviral testing. The trans-complementation system consists of two components: a genomic viral RNA containing ORF3 and envelope gene deletions, as well as mutated transcriptional regulator sequences, and a producer cell line expressing the two deleted genes. Trans-complementation of the two components generates virions that can infect naive cells for only one round but does not produce wild-type SARS-CoV-2. Hamsters and K18-hACE2 transgenic mice inoculated with the complementation-derived virions exhibited no detectable disease, even after intracranial inoculation with the highest possible dose. Thus, the trans-complementation platform can be safely used at BSL-2 laboratories for research and countermeasure development.

摘要

培养严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)需要达到生物安全级别 3(BSL-3),这是研究的一个瓶颈。在这里,我们报告了一种转互补系统,可以产生单轮感染性 SARS-CoV-2,重现真实的病毒复制。我们证明,单轮感染性 SARS-CoV-2 可在 BSL-2 实验室中用于高通量中和和抗病毒测试。该转互补系统由两个组件组成:一个基因组病毒 RNA,包含 ORF3 和包膜基因缺失以及突变转录调节序列,以及一个表达两个缺失基因的生产细胞系。两个组件的转互补产生了只能感染原始细胞一轮的病毒粒子,但不会产生野生型 SARS-CoV-2。用互补衍生的病毒粒子接种的仓鼠和 K18-hACE2 转基因小鼠没有表现出可检测到的疾病,即使在颅内接种了尽可能高的剂量。因此,该转互补平台可在 BSL-2 实验室中安全用于研究和对策开发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51a/7901297/b7225b2157a4/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51a/7901297/a18fbc3be517/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51a/7901297/456920f7cb3b/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51a/7901297/3892fb691cf5/figs1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51a/7901297/f8c215856caa/figs2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51a/7901297/133488199b04/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51a/7901297/077037d8f89c/figs3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51a/7901297/9e344b1bbdb6/figs4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51a/7901297/8069d4a8f0ea/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51a/7901297/e324e57db8f2/figs5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51a/7901297/b7225b2157a4/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51a/7901297/a18fbc3be517/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51a/7901297/456920f7cb3b/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51a/7901297/3892fb691cf5/figs1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51a/7901297/f8c215856caa/figs2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51a/7901297/133488199b04/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51a/7901297/077037d8f89c/figs3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51a/7901297/9e344b1bbdb6/figs4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51a/7901297/8069d4a8f0ea/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51a/7901297/e324e57db8f2/figs5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51a/7901297/b7225b2157a4/gr4_lrg.jpg

相似文献

1
A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence.SARS-CoV-2 的转互补系统再现了真实的病毒复制而没有毒力。
Cell. 2021 Apr 15;184(8):2229-2238.e13. doi: 10.1016/j.cell.2021.02.044. Epub 2021 Feb 23.
2
A -complementation system for SARS-CoV-2.一种针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的α-互补系统。
bioRxiv. 2021 Jan 19:2021.01.16.426970. doi: 10.1101/2021.01.16.426970.
3
A BSL-2 compliant mouse model of SARS-CoV-2 infection for efficient and convenient antiviral evaluation.一种符合 BSL-2 标准的 SARS-CoV-2 感染的小鼠模型,用于高效便捷地评估抗病毒药物。
J Virol. 2024 Jul 23;98(7):e0050424. doi: 10.1128/jvi.00504-24. Epub 2024 Jun 20.
4
Development of a Single-Cycle Infectious SARS-CoV-2 Virus Replicon Particle System for Use in Biosafety Level 2 Laboratories.开发一种用于二级生物安全实验室的单周期传染性 SARS-CoV-2 病毒复制子颗粒系统。
J Virol. 2022 Feb 9;96(3):e0183721. doi: 10.1128/JVI.01837-21. Epub 2021 Dec 1.
5
Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing.用于高通量抗病毒筛选和测试的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)报告基因复制子的构建
Proc Natl Acad Sci U S A. 2021 Apr 13;118(15). doi: 10.1073/pnas.2025866118.
6
A novel cell culture system modeling the SARS-CoV-2 life cycle.一种新型的细胞培养系统,可模拟 SARS-CoV-2 的生命周期。
PLoS Pathog. 2021 Mar 12;17(3):e1009439. doi: 10.1371/journal.ppat.1009439. eCollection 2021 Mar.
7
The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.K18-Human ACE2 转基因小鼠模型对 SARS-CoV-2 病毒感染剂量的反应可重现非重症和重症 COVID-19。
J Virol. 2022 Jan 12;96(1):e0096421. doi: 10.1128/JVI.00964-21. Epub 2021 Oct 20.
8
Design and Application of Biosafe Coronavirus Engineering Systems without Virulence.无毒性冠状病毒工程系统的设计与应用。
Viruses. 2024 Apr 24;16(5):659. doi: 10.3390/v16050659.
9
Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.SARS-CoV-2 辅助蛋白对 K18 人 ACE2 转基因小鼠病毒致病性的贡献。
J Virol. 2021 Aug 10;95(17):e0040221. doi: 10.1128/JVI.00402-21.
10
Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.传染性克隆产生的 SARS-CoV-2 可导致感染 K18-Human ACE2 小鼠发生严重肺部疾病。
mBio. 2021 Apr 20;12(2):e00819-21. doi: 10.1128/mBio.00819-21.

引用本文的文献

1
Engineering virus-like particles for safe and versatile modeling of SARS-CoV-2 host interaction and immune escape.工程化病毒样颗粒用于安全且通用的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)宿主相互作用和免疫逃逸建模
Commun Biol. 2025 Aug 30;8(1):1322. doi: 10.1038/s42003-025-08768-4.
2
The Era of Gene Therapy: The Advancement of Lentiviral Vectors and Their Pseudotyping.基因治疗时代:慢病毒载体及其假型化的进展
Viruses. 2025 Jul 24;17(8):1036. doi: 10.3390/v17081036.
3
Deletion of the Envelope gene attenuates SARS-CoV-2 infection by altered Spike localization and increased cell-to-cell transmission.

本文引用的文献

1
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera.BNT162b2 疫苗诱导的血清对 SARS-CoV-2 刺突 69/70 缺失、E484K 和 N501Y 变异株的中和作用。
Nat Med. 2021 Apr;27(4):620-621. doi: 10.1038/s41591-021-01270-4. Epub 2021 Feb 8.
2
A PCR amplicon-based SARS-CoV-2 replicon for antiviral evaluation.基于 PCR 扩增子的 SARS-CoV-2 复制子用于抗病毒评估。
Sci Rep. 2021 Jan 26;11(1):2229. doi: 10.1038/s41598-021-82055-0.
3
Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis.
包膜基因的缺失通过改变刺突蛋白的定位和增加细胞间传播来减弱新冠病毒感染。
bioRxiv. 2025 May 23:2025.05.20.655126. doi: 10.1101/2025.05.20.655126.
4
SARS-CoV-2 virus lacking the envelope and membrane open-reading frames as a vaccine platform.缺乏包膜和膜开放阅读框的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒作为一种疫苗平台
Nat Commun. 2025 May 14;16(1):4453. doi: 10.1038/s41467-025-59533-4.
5
Genetic Conservation and Diversity of SARS-CoV-2 Envelope Gene Across Variants of Concern.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)包膜基因在关注变异株中的遗传保守性和多样性
J Med Virol. 2025 Jan;97(1):e70136. doi: 10.1002/jmv.70136.
6
Dimming the corona: studying SARS-coronavirus-2 at reduced biocontainment level using replicons and virus-like particles.弱化冠状病毒:使用复制子和病毒样颗粒在降低生物安全防护水平下研究严重急性呼吸综合征冠状病毒2
mBio. 2024 Dec 11;15(12):e0336823. doi: 10.1128/mbio.03368-23. Epub 2024 Nov 12.
7
High protection and transmission-blocking immunity elicited by single-cycle SARS-CoV-2 vaccine in hamsters.单周期SARS-CoV-2疫苗在仓鼠中引发的高保护性和传播阻断免疫力。
NPJ Vaccines. 2024 Oct 30;9(1):206. doi: 10.1038/s41541-024-00992-z.
8
Requirement of the N-terminal region of nonstructural protein 1 in cis for SARS-CoV-2 defective RNA replication.非结构蛋白 1 N 端区域在 SARS-CoV-2 缺陷型 RNA 复制中的顺式需求。
J Virol. 2024 Sep 17;98(9):e0090024. doi: 10.1128/jvi.00900-24. Epub 2024 Aug 28.
9
RNA replication-independent, DNA linearization-dependent expression of reporter genes from a SARS-CoV-2 replicon-encoding DNA in human cells.在人细胞中,来自编码 SARS-CoV-2 复制子的 DNA 的报告基因,在 RNA 复制非依赖性、DNA 线性化依赖性条件下表达。
PLoS One. 2024 Aug 16;19(8):e0300491. doi: 10.1371/journal.pone.0300491. eCollection 2024.
10
A Cullin 5-based complex serves as an essential modulator of ORF9b stability in SARS-CoV-2 replication.一个基于 Cullin 5 的复合物作为 SARS-CoV-2 复制中 ORF9b 稳定性的重要调节剂。
Signal Transduct Target Ther. 2024 Jun 28;9(1):159. doi: 10.1038/s41392-024-01874-5.
去除furin 酶切位点可减轻 SARS-CoV-2 的发病机制。
Nature. 2021 Mar;591(7849):293-299. doi: 10.1038/s41586-021-03237-4. Epub 2021 Jan 25.
4
Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape.用于预防 SARS-CoV-2 逃逸的抗体鸡尾酒的分子决定因素和机制。
Nat Commun. 2021 Jan 20;12(1):469. doi: 10.1038/s41467-020-20789-7.
5
Fast-spreading U.K. virus variant raises alarms.传播迅速的英国病毒变种引发警报。
Science. 2021 Jan 1;371(6524):9-10. doi: 10.1126/science.371.6524.9.
6
Structure and dynamics of membrane protein in SARS-CoV-2.新冠病毒膜蛋白的结构与动力学
J Biomol Struct Dyn. 2022 Jul;40(10):4725-4738. doi: 10.1080/07391102.2020.1861983. Epub 2020 Dec 22.
7
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.SARS-CoV-2 mRNA-1273疫苗接种后反应的持久性。
N Engl J Med. 2021 Jan 7;384(1):80-82. doi: 10.1056/NEJMc2032195. Epub 2020 Dec 3.
8
The Structure of the Membrane Protein of SARS-CoV-2 Resembles the Sugar Transporter SemiSWEET.新型冠状病毒(SARS-CoV-2)膜蛋白的结构类似于糖转运蛋白SemiSWEET。
Pathog Immun. 2020 Oct 19;5(1):342-363. doi: 10.20411/pai.v5i1.377. eCollection 2020.
9
Spike mutation D614G alters SARS-CoV-2 fitness.刺突突变 D614G 改变了 SARS-CoV-2 的适应性。
Nature. 2021 Apr;592(7852):116-121. doi: 10.1038/s41586-020-2895-3. Epub 2020 Oct 26.
10
A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19.一种纳米荧光素酶 SARS-CoV-2,可用于快速中和试验和筛选抗 COVID-19 抗感染药物。
Nat Commun. 2020 Oct 15;11(1):5214. doi: 10.1038/s41467-020-19055-7.